HIV and thyroid dysfunction

Reviews in Endocrine and Metabolic Disorders

Volumn 14, Issue 2, 2013, Pages 127-131

  Parsa, Alan A ^a   Bhangoo, Amrit ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b MILLER CHILDREN S HOSPITAL   (United States)

Author keywords

AIDS; Graves' disease; HIV; Hyperthyroidism; Hypothyroidism; Subclinical thyroid dysfunction

Indexed keywords

3,3',5' TRIIODOTHYRONINE; LEVOTHYROXINE; LIOTHYRONINE; PROTIRELIN; RADIOACTIVE IODINE; THIAMAZOLE; THYROTROPIN; THYROXINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COLD; CONSTIPATION; DEIODINATION; DISEASE ASSOCIATION; DRY SKIN; EUTHYROID SICK SYNDROME; FINE NEEDLE ASPIRATION BIOPSY; FREE THYROXINE INDEX; GLUCURONIDATION; GOITER; GRAVES DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERTHYROIDISM; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; KAPOSI SARCOMA; LONG TERM CARE; OPPORTUNISTIC INFECTION; OSTEOPOROSIS; REMISSION; RESTING ENERGY EXPENDITURE; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; THYROID DISEASE; THYROID FUNCTION; THYROXINE BLOOD LEVEL; VOICE CHANGE; WEIGHT REDUCTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; GRAVES DISEASE; HIV INFECTIONS; HUMANS; HYPOTHYROIDISM; MODELS, BIOLOGICAL; THYROID DISEASES; THYROID GLAND;

EID: 84879696165     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-013-9248-6     Document Type: Article

References (51)

1. Boelaert K, Franklyn JA. Thyroid hormone in health and disease. J Endocrinol. 2005;187:1-15.
2. Franklyn JA. The thyroid- too much and too little across the ages. The consequences of subclinical thyroid dysfunction. Clin Endocrinol. 2013;78(1):1-8.
3. Grunfeld C, Pang M, Doerrier W, et al. Indices of thyroid function and weight loss in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism. 1993;42(10):1270-6.
4. Olivieri A, Sorcini M, Battisti P, et al. Thyroid hypofunction related with the progression of human immunodeficiency virus infection. J Endocrinol Invest. 1993;16:407-13.
5. Kosmiski L. Energy expenditure in HIV infection. Am J Clin Nutr. 2011;94(6):16775-825.
6. Mittelsteadt AL, Hileman CO, Harris SR, et al. Effects of HIV and antiretroviral therapy on resting energy expenditure in adult HIV-infected women - a matched, prospective, cross-sectional study. J Acad Nutr Diet. 2013. doi: 10.1016/j.jand.2013.02.005.
7. Mangili A, Murman DH, Zampini AM, Wanke CA, Mayer KH. Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort. Clin Infect Dis. 2006;42(6):836-42.
8. Hirschfeld S, Laue L, Cutler Jr GB, Pizzo PA. Thyroid abnormalities in children infected with human immunodeficiency virus. J Pediatr. 1996;128(1):70-4.
9. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489.
10. Golden SH, Robinson KA, Saldanha I, et al. Prevalence and incidence of endocrine and metabolic disorders in the United Staes: a comprehensive review. J Clin Endocrinol Metab. 2009;94(6):1853-78.
11. Beltran S, Lescure F-X, Esper IE, et al. Subclinical hypothyroidism in HIV infected patients is not an autoimmune disease. Horm Res. 2006;66:21-6.
12. Madge S, Smith C, Lampe F, et al. No association between HIV disease and its treatment and thyroid function. HIV Med. 2006;7(supp 1):23. abstract P49.
13. Noureldeen A, Qusti SY, Khoja GM. Thyroid function in newly diagnosed HIV-infected patients. Toxicol Ind Health. 2012. doi: 10.1177/0748233712466133.
14. Fundaro C, Olivieri A, Rendeli C, et al. Occurrence of anti-thyroid autoantibodies in children vertically infected with HIV-1. J Pediatr Endocrinol Metab. 1998;11(6):745-50.
15. Chiarelli F, Galli L, Verrotti A, et al. Thyroid function in children with perinatal human immunodeficiency virus type 1 infection. Thyroid. 2000;10(6):499-505.
16. Rana S, Nunlee-Bland G, Valyasevi R, Iqbal M. Thyroid dysfunction in HIV-infected children: is L-thyroxine therapy beneficial? Pediatr AIDS HIV Infect. 1996;7(6):424-8.
17. Marino R, Hegde A, Barnes KM, et al. Catch up growth after hypothyroidism is caused by delayed growth plate senescence. Endocrinology. 2008;149(4):1820-8.
18. Touzot M, Le Beller C, Touzot F, et al. Dramatic interaction between levothyroxine and lopinavir/ritonavir in an HIV infected patient. AIDS. 2006;20:1210-2.
19. Lanzafame M, Trevenzoli M, Faggian F, et al. Interaction between levothyroxine and indinavir in a patient with HIV infection. Infection. 2002;30(1):54-5.
20. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: co-sponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;11:1-207.
21. Beltran S, Lescure F-X, Desailloud R, et al. Increased prevalence of hypothyroidism among human immunodeficiency virus- infected patients: a need for screening. Clin Infect Dis. 2003;37:579-83.
22. Merenich J, McDermott T, Asp A, et al. Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. J Clin Endocrinol Metab. 1990;70:566-71.
23. Quirino T, Bongiovanni M, Ricci E, et al. Hypothyroidism in HIV-infected patients who have or have not received HAART. Clin Infect Dis. 2004;38(4):596-7.
24. Madeddu G, Spanu A, Chessa F, et al. Thyroid function in human immunodeficiency virus patients treathed with highly active antiretroviral therapy (HAART): a longitudinal study. Clin Endocrinol. 2006;64:375-83.
25. Calza L, Manfredi R, Chiodo F. Subclinical hypothyroidism in HIV-infected patients receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31:361-2.
26. Bongiovanni M, Adorni F, Casana M, et al. Subclinical hypothyroidism in HIV-infected patients. J Antimicrob Chemother. 2006;58(5):1086-9.
27. Grappin M, Piroth L, Verges B, et al. Increased prevalence of subclinical hypothyroidism in HIV patients treated with highly active antiretroviral therapy. AIDS. 2000;14:1070-2.
28. Hoffman CJ, Brown TT. Thyroid function abnormalities in HIV-infected patients. Clin Infect Dis. 2007;45:488-94.
29. Sellmeyer DE, Grrunfeld C. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev. 1996;17:518-27.
30. Dobs AS, Dempsy MA, Ladenson PW, Polk BF. Endocrine disorders in men infected with the human immunodeficiency virus. Am J Med. 1988;84:611-6.
31. Collazos J, Ibarra S, Mayo J. Thyroid hormones in HIV infected patients in the highly active antiretroviral therapy era: evidence of an interrelationship between the thyroid axis and the immune system. AIDS. 2004;17:763-5.
32. Vigano A, Riboni S, Bianchi R, et al. Thyroid dysfunction in antiretroviral treated children. Pediatr Infect Dis J. 2004;23(3):235-9.
33. Raffi F, Brisseau JM, Planchon et al. Endocrine function in 98 HIV- infected patients: a prospective study. AIDS. 1991;5:729-733
34. Zavaschi AP, Maia AL, Goldani LA. Pneumocystis jiroveci thyroiditis: report of 15 cases in the literature. Mycoses. 2007;50(6):443-6.
35. Jinno S, Chang S, Jocobs MR. Coccidioides thyroiditis in an HIV-infected patient. J Clin Microbiol. 2012;50(7):2535-7.
36. Kiertiburanakul S, Sungkanuparph S, Malathum K, Pracharktam R. Concomitant tuberculous and cryptococcal thyroid abscess in a human immunodeficiency virus infected patient. Scand J Infect Dis. 2003;35(1):68-70.
37. Trzepacz PT, McCue M, Klein I, et al. Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms. Am J Med. 1989;87:558-61.
38. Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593-646.
39. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348:2646-55.
40. Chen F, Day SL, Metcalfe RA, et al. Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine. 2005;84(2):98-106.
41. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396:690-5.
42. Pakker NG, Notermans DW, de Boer RJ, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med. 1998;4(2):208.
43. Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD + T cell homeostasis and function in advanced HIV disease. Science. 1997;277(5322):112-6.
44. Imami N, Antonopoulos C, Hardy GA, et al. Assessment of type 1 and type 2 cytokines in HIC type 1 infected individuals: impact of highly active antiretroviral therapy. AIDS Res Hum Retrovir. 1999;15:1499-508.
45. Mullur M, Wandel S, Colebunders R, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(4):251-61.
46. Grant PM, Komarow L, Andersen J, et al. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS One. 2010. 5(7). doi: 10.1371/journal.pone.0011416
47. Jubault V, Penfornis A, Schillo F, et al. Sequential occurance of thyroid autoantibodies and Graves disease after immune restoration in severely immunocompromised human immunodeficiency virus-1 infected patients. J Clin Endocrinol Metab. 2000;85:4254-7.
48. Vos F, Pieters G, Keuter M, van der Ven A. Graves' disease during immune reconstitution in HIV infected patients treated with HAART. Scand J Infect Dis. 2006;38(2):124-6.
49. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249-52.
50. Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295:1033-41.
51. Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352:905-917.